NCT02609893View on ClinicalTrials.gov

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

August 31, 2019

Conditions
Chronic Hepatitis C
Interventions
OTHER

modified directly observed therapy (mDOT)

OTHER

unobserved dosing

OTHER

Motivational Interviewing-based counseling

Motivational Interviewing-based risk reduction and medication adherence counseling

Trial Locations (1)

94102

Substance Use Research Unit, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Phillip Coffin, MD, MIA

OTHER_GOV

NCT02609893 - Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs | Biotech Hunter | Biotech Hunter